Literature DB >> 27073477

Structure, functional regulation and signaling properties of Rap2B.

Debao Qu1, Hui Huang2, Jiehui DI3, Keyu Gao2, Zheng Lu2, Junnian Zheng4.   

Abstract

The Ras family small guanosine 5'-triphosphate (GTP)-binding protein Rap2B is is a member of the Ras oncogene family and a novel target of p53 that regulates the p53-mediated pro-survival function of cells. The Rap2B protein shares ~90% homology with Rap2A, and its sequence is 70% identical to other members of the Rap family such as RaplA and RaplB. As a result, Rap2B has been theorized to have similar signaling effectors to the GTPase-binding protein Rap, which mediates various biological functions, including the regulation of sterile 20/mitogen-activated proteins. Since its identification in the early 1990s, Rap2B has elicited a considerable interest. Numerous studies indicate that Rap2B exerts specific biological functions, including binding and stimulating phospholipase C-ε and interferon-γ. In addition, downregulation of Rap2B affects the growth of melanoma cells. The present review summarizes the possible effectors and biological functions of Rap2B. Increasing evidence clearly supports the association between Rap2B function and tumor development. Therefore, it is conceivable that anticancer drugs targeting Rap2B may be generated as novel therapies against cancer.

Entities:  

Keywords:  Rap2B; biological function; cancer; effector; structure

Year:  2016        PMID: 27073477      PMCID: PMC4812151          DOI: 10.3892/ol.2016.4261

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  105 in total

1.  Mechanism of regulation of the Epac family of cAMP-dependent RapGEFs.

Authors:  J de Rooij; H Rehmann; M van Triest; R H Cool; A Wittinghofer; J L Bos
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

2.  Phospholipase C(epsilon): a novel Ras effector.

Authors:  G G Kelley; S E Reks; J M Ondrako; A V Smrcka
Journal:  EMBO J       Date:  2001-02-15       Impact factor: 11.598

3.  RAP2B: a RAS-related GTP-binding protein from platelets.

Authors:  C A Ohmstede; F X Farrell; B R Reep; K J Clemetson; E G Lapetina
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 4.  Stimulation of phospholipase Cbeta by membrane interactions, interdomain movement, and G protein binding--how many ways can you activate an enzyme?

Authors:  Guillaume Drin; Suzanne Scarlata
Journal:  Cell Signal       Date:  2007-04-29       Impact factor: 4.315

5.  Suppression of Ras-stimulated transformation by the JNK signal transduction pathway.

Authors:  Norman J Kennedy; Hayla K Sluss; Stephen N Jones; Dafna Bar-Sagi; Richard A Flavell; Roger J Davis
Journal:  Genes Dev       Date:  2003-03-01       Impact factor: 11.361

6.  The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells.

Authors:  F Bost; R McKay; M Bost; O Potapova; N M Dean; D Mercola
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

7.  Staphylococcus aureus promotes autophagy by decreasing intracellular cAMP levels.

Authors:  Maria Belén Mestre; María Isabel Colombo
Journal:  Autophagy       Date:  2012-10-09       Impact factor: 16.016

8.  The Traf2- and Nck-interacting kinase as a putative effector of Rap2 to regulate actin cytoskeleton.

Authors:  Kiyohito Taira; Masato Umikawa; Kimiko Takei; Bat-Erdene Myagmar; Manabu Shinzato; Noriko Machida; Hiroshi Uezato; Shigeo Nonaka; Ken-ichi Kariya
Journal:  J Biol Chem       Date:  2004-09-01       Impact factor: 5.157

9.  Prenyl group identification of rap2 proteins: a ras superfamily member other than ras that is farnesylated.

Authors:  F X Farrell; K Yamamoto; E G Lapetina
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

Review 10.  Anti-tumour strategies aiming to target tumour-associated macrophages.

Authors:  Xiaoqiang Tang; Chunfen Mo; Yongsheng Wang; Dandan Wei; Hengyi Xiao
Journal:  Immunology       Date:  2013-02       Impact factor: 7.397

View more
  7 in total

1.  The Impact of p53 on Aristolochic Acid I-Induced Gene Expression In Vivo.

Authors:  Mateja Sborchia; Hector C Keun; David H Phillips; Volker M Arlt
Journal:  Int J Mol Sci       Date:  2019-12-06       Impact factor: 5.923

2.  Knockdown of Rap2B Inhibits the Proliferation and Invasion in Hepatocellular Carcinoma Cells.

Authors:  Li Zhang; Hong-Bin Duan; Yun-Sheng Yang
Journal:  Oncol Res       Date:  2017-01-02       Impact factor: 5.574

3.  Identification and Analysis of the Blood lncRNA Signature for Liver Cirrhosis and Hepatocellular Carcinoma.

Authors:  Qi Xia; Zheyue Shu; Ting Ye; Min Zhang
Journal:  Front Genet       Date:  2020-12-07       Impact factor: 4.599

4.  Screening of Specific and Common Pathways in Breast Cancer Cell Lines MCF-7 and MDA-MB-231 Treated with Chlorophyllides Composites.

Authors:  Keng-Shiang Huang; Yi-Ting Wang; Omkar Byadgi; Ting-Yu Huang; Mi-Hsueh Tai; Jei-Fu Shaw; Chih-Hui Yang
Journal:  Molecules       Date:  2022-06-20       Impact factor: 4.927

5.  Functional redundancy between RAP1 isoforms in murine platelet production and function.

Authors:  Lucia Stefanini; Robert H Lee; David S Paul; Ellen C O'Shaughnessy; Dorsaf Ghalloussi; Christopher I Jones; Yacine Boulaftali; Kathryn O Poe; Raymond Piatt; Dan O Kechele; Kathleen M Caron; Klaus M Hahn; Jonathan M Gibbins; Wolfgang Bergmeier
Journal:  Blood       Date:  2018-08-21       Impact factor: 22.113

6.  Long non-coding RNA CCAT1 promotes non-small cell lung cancer progression by regulating the miR-216a-5p/RAP2B axis.

Authors:  Lingling Pang; Qianqian Zhang; Yanmin Wu; Qingru Yang; Jinghao Zhang; Yuanyuan Liu; Ruoran Li
Journal:  Exp Biol Med (Maywood)       Date:  2020-10-06

7.  Molecular Associations and Clinical Significance of RAPs in Hepatocellular Carcinoma.

Authors:  Sarita Kumari; Mohit Arora; Jay Singh; Lokesh K Kadian; Rajni Yadav; Shyam S Chauhan; Anita Chopra
Journal:  Front Mol Biosci       Date:  2021-06-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.